文献速递慢病防控与筛查卫生政策与健康促进

可修饰树状大分子纳米颗粒平台用于可卡因疫苗接种

Vaccination against cocaine using a modifiable dendrimer nanoparticle platform.
PubMed 文献 · Vaccine · 2020-11-03

针对可卡因成瘾缺乏有效药物治疗的现状,本研究将可卡因类似物偶联至含MHC II结合部分的树状大分子纳米颗粒载体,无需佐剂即在小鼠中诱导快速、持久且高亲和力的抗可卡因抗体反应,并在大鼠条件位置偏爱模型中证明可减弱可卡因奖赏效应。

要点

  • 树状大分子纳米颗粒偶联可卡因类似物无需佐剂即可诱导高亲和力抗体。
  • 在两种近交系小鼠中,额外佐剂对该平台疫苗冗余或有害。
  • 大鼠条件位置偏爱实验支持该疫苗可减弱可卡因奖赏。

核心结论

  • 免疫靶向树状大分子可卡因疫苗具有内在效力,无需佐剂即可诱导抗可卡因抗体反应并减弱可卡因奖赏。

研究设计与样本

  • 研究将可卡因类似物偶联至含MHC II结合部分的树状大分子纳米颗粒载体,并在两种近交系小鼠和大鼠中评估免疫原性与行为学效果。

主要发现

  • 该策略无需佐剂即产生快速、持久且高亲和力的抗可卡因抗体反应。
  • 在两种近交系小鼠中评估多种佐剂配方,发现佐剂功能冗余或有害。
  • 大鼠条件位置偏爱实验证明该疫苗可减弱可卡因奖赏。

临床怎么用

  • 该平台为可卡因成瘾提供潜在主动免疫策略,并可通过替换偶联载荷设计针对其他弱免疫原性抗原的疫苗。

局限性

  • 研究主要基于小鼠和大鼠模型,尚未提供人体临床数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pharmacological therapies for the treatment of cocaine addiction have had disappointing efficacy, and the lack of recent developments in the clinical care of cocaine-addicted patients indicates a need for novel treatment strategies. Recent studies have shown that vaccination against cocaine to elicit production of antibodies that reduce concentrations of free drug in the blood is a promising method to protect against the effects of cocaine and reduce rates of relapse. However, the poorly immunogenic nature of cocaine remains a major hurdle to active immunization. Therefore, we hypothesized that strategies to increase targeted exposure of cocaine to the immune system may produce a more effective vaccine. To specifically direct an immune response against cocaine, in the present study we have conjugated a cocaine analog to a dendrimer-based nanoparticle carrier with MHC II-binding moieties that previously has been shown to activate antigen-presenting cells necessary for antibody production. This strategy produced a rapid, prolonged, and high affinity anti-cocaine antibody response without the need for an adjuvant. Surprisingly, additional evaluation using multiple adjuvant formulations in two strains of inbred mice found adjuvants were either functionally redundant or deleterious in the vaccination against cocaine using this platform. The use of conditioned place preference in rats after administration of this vaccine provided proof of concept for the ability of this vaccine to diminish cocaine reward. Together these data demonstrate the intrinsic efficacy of an immune-targeting dendrimer-based cocaine vaccine, with a vast potential for design of future vaccines against other poorly immunogenic antigens by substitution of the conjugated cargo.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lowell JA, Dikici E, Joshi PM, et al. Vaccination against cocaine using a modifiable dendrimer nanoparticle platform. Vaccine. 2020. PMID: 33158592. doi:10.1016/j.vaccine.2020.10.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。